2025-04-01 2026-03-31 2026-03-31 false 07725767 SEA Hives Ltd 72110 Research and experimental development on biotechnology iso4217:GBP xbrli:pure 07725767 2025-04-01 07725767 2026-03-31 07725767 2025-04-01 2026-03-31 07725767 bus:SmallEntities 2025-04-01 2026-03-31 07725767 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 07725767 bus:AbridgedAccounts 2025-04-01 2026-03-31 07725767 core:WithinOneYear 2026-03-31 07725767 core:AfterOneYear 2026-03-31 07725767 core:WithinOneYear 2025-04-01 2026-03-31 07725767 core:AfterOneYear 2025-04-01 2026-03-31 07725767 core:CurrentFinancialInstruments 2026-03-31 07725767 core:Non-currentFinancialInstruments 2026-03-31 07725767 core:CurrentFinancialInstruments 2025-04-01 2026-03-31 07725767 core:Non-currentFinancialInstruments 2025-04-01 2026-03-31 07725767 core:LandBuildings 2025-04-01 2026-03-31 07725767 core:FurnitureFittings 2025-04-01 2026-03-31 07725767 core:OfficeEquipment 2025-04-01 2026-03-31 07725767 core:Vehicles 2025-04-01 2026-03-31 07725767 core:PlantMachinery 2025-04-01 2026-03-31 07725767 core:OtherPropertyPlantEquipment 2025-04-01 2026-03-31 07725767 core:LandBuildings 2026-03-31 07725767 core:PlantMachinery 2026-03-31 07725767 core:Vehicles 2026-03-31 07725767 core:FurnitureFittings 2026-03-31 07725767 core:OfficeEquipment 2026-03-31 07725767 core:OtherPropertyPlantEquipment 2026-03-31 07725767 core:Right-of-useAssets 2025-04-01 2026-03-31 07725767 core:Right-of-useAssets 2026-03-31 07725767 core:Goodwill 2025-04-01 2026-03-31 07725767 core:PatentsTrademarksLicencesConcessionsSimilar 2025-04-01 2026-03-31 07725767 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-04-01 2026-03-31 07725767 core:OtherResidualIntangibleAssets 2025-04-01 2026-03-31 07725767 core:Goodwill 2026-03-31 07725767 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2026-03-31 07725767 core:PatentsTrademarksLicencesConcessionsSimilar 2026-03-31 07725767 core:OtherResidualIntangibleAssets 2026-03-31 07725767 dpl:CostSales 2025-04-01 2026-03-31 07725767 dpl:AdministrativeExpenses 2025-04-01 2026-03-31 07725767 dpl:DistributionCosts 2025-04-01 2026-03-31 07725767 core:ShareCapital 2026-03-31 07725767 core:SharePremium 2026-03-31 07725767 core:RevaluationReserve 2026-03-31 07725767 core:OtherReservesSubtotal 2026-03-31 07725767 core:ShareCapitalPreferenceShares 2026-03-31 07725767 core:CapitalRedemptionReserve 2026-03-31 07725767 core:OtherCapitalReserve 2026-03-31 07725767 core:RetainedEarningsAccumulatedLosses 2026-03-31 07725767 core:ShareCapital 2025-04-01 2026-03-31 07725767 core:SharePremium 2025-04-01 2026-03-31 07725767 core:RevaluationReserve 2025-04-01 2026-03-31 07725767 core:OtherReservesSubtotal 2025-04-01 2026-03-31 07725767 core:RetainedEarningsAccumulatedLosses 2025-04-01 2026-03-31 07725767 1 2025-04-01 2026-03-31 07725767 2 2025-04-01 2026-03-31 07725767 core:ShareCapital 1 2025-04-01 2026-03-31 07725767 core:ShareCapital 2 2025-04-01 2026-03-31 07725767 core:SharePremium 1 2025-04-01 2026-03-31 07725767 core:SharePremium 2 2025-04-01 2026-03-31 07725767 core:RevaluationReserve 1 2025-04-01 2026-03-31 07725767 core:RevaluationReserve 2 2025-04-01 2026-03-31 07725767 core:RetainedEarningsAccumulatedLosses 1 2025-04-01 2026-03-31 07725767 core:RetainedEarningsAccumulatedLosses 2 2025-04-01 2026-03-31 07725767 1 2025-04-01 2026-03-31 07725767 core:Non-currentFinancialInstruments core:CostValuation 2025-04-01 07725767 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2026-03-31 07725767 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2026-03-31 07725767 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2026-03-31 07725767 core:Non-currentFinancialInstruments core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments 2026-03-31 07725767 core:Non-currentFinancialInstruments core:CostValuation 2026-03-31 07725767 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2025-04-01 07725767 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2026-03-31 07725767 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2026-03-31 07725767 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2026-03-31 07725767 core:Non-currentFinancialInstruments core:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal 2026-03-31 07725767 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2026-03-31 07725767 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2026-03-31 07725767 core:Non-currentFinancialInstruments 2026-03-31 07725767 core:Non-currentFinancialInstruments 2025-03-31 07725767 2024-04-01 07725767 2025-03-31 07725767 2024-04-01 2025-03-31 07725767 core:WithinOneYear 2025-03-31 07725767 core:AfterOneYear 2025-03-31 07725767 core:CurrentFinancialInstruments 2025-03-31 07725767 core:Non-currentFinancialInstruments 2025-03-31 07725767 core:LandBuildings 2025-03-31 07725767 core:PlantMachinery 2025-03-31 07725767 core:Vehicles 2025-03-31 07725767 core:FurnitureFittings 2025-03-31 07725767 core:OfficeEquipment 2025-03-31 07725767 core:OtherPropertyPlantEquipment 2025-03-31 07725767 core:Right-of-useAssets 2025-03-31 07725767 core:Goodwill 2025-03-31 07725767 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-03-31 07725767 core:PatentsTrademarksLicencesConcessionsSimilar 2025-03-31 07725767 core:OtherResidualIntangibleAssets 2025-03-31 07725767 dpl:AdministrativeExpenses 2024-04-01 2025-03-31 07725767 core:ShareCapital 2025-03-31 07725767 core:SharePremium 2025-03-31 07725767 core:RevaluationReserve 2025-03-31 07725767 core:OtherReservesSubtotal 2025-03-31 07725767 core:ShareCapitalPreferenceShares 2025-03-31 07725767 core:CapitalRedemptionReserve 2025-03-31 07725767 core:OtherCapitalReserve 2025-03-31 07725767 core:RetainedEarningsAccumulatedLosses 2025-03-31 07725767 core:RetainedEarningsAccumulatedLosses 2024-04-01 07725767 core:ShareCapital 2024-04-01 07725767 core:SharePremium 2024-04-01 07725767 core:RevaluationReserve 2024-04-01 07725767 core:ShareCapital 2024-04-01 2025-03-31 07725767 core:SharePremium 2024-04-01 2025-03-31 07725767 core:RevaluationReserve 2024-04-01 2025-03-31 07725767 core:OtherReservesSubtotal 2024-04-01 2025-03-31 07725767 core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 07725767 1 2024-04-01 2025-03-31 07725767 2 2024-04-01 2025-03-31 07725767 core:ShareCapital 1 2024-04-01 2025-03-31 07725767 core:ShareCapital 2 2024-04-01 2025-03-31 07725767 core:SharePremium 1 2024-04-01 2025-03-31 07725767 core:SharePremium 2 2024-04-01 2025-03-31 07725767 core:RevaluationReserve 1 2024-04-01 2025-03-31 07725767 core:RevaluationReserve 2 2024-04-01 2025-03-31 07725767 core:RetainedEarningsAccumulatedLosses 1 2024-04-01 2025-03-31 07725767 core:RetainedEarningsAccumulatedLosses 2 2024-04-01 2025-03-31 07725767 bus:Director1 2025-04-01 2026-03-31 07725767 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31
SEA Hives Ltd
Unaudited Financial Statements
for the year ended 31 March 2026
Company registration number 07725767
(England and Wales)

# Company Information

For the year ended 31 March 2026

Director | Francis, David Charles

Registered office | Walker House
| Market Place
| Somerton
| TA11 7LZ

Registered number | 07725767

Accountant | Blue Lias Accounting Limited
| Walker House
| Market Place
| Somerton
| Somerset
| TA11 7LX

# Statement of Financial Position

As at 31 March 2026

| Notes |
2026
2025
£
£
£
£
Fixed assets
Tangible assets
8,240
8,089
8,240
8,089
Current assets
Stocks
| 5 |
319
185
Cash at bank and in hand
| 6 |
402
2,365
721
2,550
Creditors
Amounts falling due within one year
| 7 |
(34,277)
(30,802)
(34,277)
(30,802)
Net current assets (liabilities)
(33,556)
(28,252)
Total assets less current liabilities
(25,316)
(20,163)
Net assets (liabilities)
(25,316)
(20,163)
Capital and reserves
Called up share capital
| 8 |
102
102
Profit and loss account
(25,418)
(20,265)
Total equity
(25,316)
(20,163)

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444 (2A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the director on 20 August 2026 and are signed on its behalf by:

Francis, David Charles Francis, David Charles Director |

Company registration number 07725767

# Notes to the Financial Statements

For the year ended 31 March 2026

### 1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

### 2. Accounting policies

### 2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

### 2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.

Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

### 2.3. Interest receivable

Interest income is recognised using the effective interest rate method.

### 2.4. Tangible fixed assets and depreciation

All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

### 3. Employees

The average number of employees during the year was 0 (2025: 0).

### 4. Tangible fixed assets

Total
£
Cost
At 1 April 2025
9,564
Additions
315
At 31 March 2026
9,879
Depreciation and impairment
At 1 April 2025
1,475
Charge for the period
164
At 31 March 2026
1,639
Net book value
At 31 March 2026
8,240
At 31 March 2025
8,089

### 5. Stocks and work in progress

2026
2025
£
£
Other stocks
319
185
Total
319
185

### 6. Cash at bank and in hand

2026
2025
£
£
Cash at bank
402
2,365
Total
402
2,365

### 7. Creditors due within one year

2026
2025
£
£
Directors loan account
33,603
30,187
Accruals and deferred income
674
615
Total
34,277
30,802

### 8. Share capital

2026
2025
£
£
Allotted, called up and fully paid
Ordinary Shares
102
102
Total
102
102